Effect of probucol in lecithin-cholesterol acyltransferase - Deficient mice

Inhibition of 2 independent cellular cholesterol - Releasing pathways in vivo

Shigehiro Tomimoto, Maki Tsujita, Mitsuyo Okazaki, Shinichi Usui, Toyohiro Tada, Tatsuya Fukutomi, Shigenori Ito, Makoto Itoh, Shinji Yokoyama

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2%) and high (1.2%) cholesterol diets containing 0.5% probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol-fed female mice and in the thyroid gland of the low cholesterol-fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice but not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.

Original languageEnglish
Pages (from-to)394-400
Number of pages7
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume21
Issue number3
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Probucol
Phosphatidylcholine-Sterol O-Acyltransferase
Cholesterol
HDL Lipoproteins
Lecithin Cholesterol Acyltransferase Deficiency
Apolipoproteins
Liver
Cell Communication
Thyroid Gland
Homeostasis
Spleen
Diet
Adrenal Glands

Keywords

  • Cholesterol efflux
  • Cholesterol homeostasis
  • High density lipoproteins
  • Lecithin-cholesterol acyltransferase
  • Probucol

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of probucol in lecithin-cholesterol acyltransferase - Deficient mice : Inhibition of 2 independent cellular cholesterol - Releasing pathways in vivo. / Tomimoto, Shigehiro; Tsujita, Maki; Okazaki, Mitsuyo; Usui, Shinichi; Tada, Toyohiro; Fukutomi, Tatsuya; Ito, Shigenori; Itoh, Makoto; Yokoyama, Shinji.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 21, No. 3, 2001, p. 394-400.

Research output: Contribution to journalArticle

Tomimoto, Shigehiro ; Tsujita, Maki ; Okazaki, Mitsuyo ; Usui, Shinichi ; Tada, Toyohiro ; Fukutomi, Tatsuya ; Ito, Shigenori ; Itoh, Makoto ; Yokoyama, Shinji. / Effect of probucol in lecithin-cholesterol acyltransferase - Deficient mice : Inhibition of 2 independent cellular cholesterol - Releasing pathways in vivo. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2001 ; Vol. 21, No. 3. pp. 394-400.
@article{4ed4677b83c74353945641754c244394,
title = "Effect of probucol in lecithin-cholesterol acyltransferase - Deficient mice: Inhibition of 2 independent cellular cholesterol - Releasing pathways in vivo",
abstract = "Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2{\%}) and high (1.2{\%}) cholesterol diets containing 0.5{\%} probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol-fed female mice and in the thyroid gland of the low cholesterol-fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice but not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.",
keywords = "Cholesterol efflux, Cholesterol homeostasis, High density lipoproteins, Lecithin-cholesterol acyltransferase, Probucol",
author = "Shigehiro Tomimoto and Maki Tsujita and Mitsuyo Okazaki and Shinichi Usui and Toyohiro Tada and Tatsuya Fukutomi and Shigenori Ito and Makoto Itoh and Shinji Yokoyama",
year = "2001",
language = "English",
volume = "21",
pages = "394--400",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Effect of probucol in lecithin-cholesterol acyltransferase - Deficient mice

T2 - Inhibition of 2 independent cellular cholesterol - Releasing pathways in vivo

AU - Tomimoto, Shigehiro

AU - Tsujita, Maki

AU - Okazaki, Mitsuyo

AU - Usui, Shinichi

AU - Tada, Toyohiro

AU - Fukutomi, Tatsuya

AU - Ito, Shigenori

AU - Itoh, Makoto

AU - Yokoyama, Shinji

PY - 2001

Y1 - 2001

N2 - Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2%) and high (1.2%) cholesterol diets containing 0.5% probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol-fed female mice and in the thyroid gland of the low cholesterol-fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice but not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.

AB - Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2%) and high (1.2%) cholesterol diets containing 0.5% probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol-fed female mice and in the thyroid gland of the low cholesterol-fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice but not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.

KW - Cholesterol efflux

KW - Cholesterol homeostasis

KW - High density lipoproteins

KW - Lecithin-cholesterol acyltransferase

KW - Probucol

UR - http://www.scopus.com/inward/record.url?scp=0035093091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035093091&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 394

EP - 400

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 3

ER -